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Abstract
Molecular signaling is an exponentially growing field that encompasses different molecular aspects
of cell signaling underlying normal and pathological conditions. This area also focuses on defining
the genetic and epigenetic changes that modulate the signaling properties of cells and the resultant
physiological as well as pathological conditions. Therefore, rapid publication of results from these
endeavors and, more importantly, free access to such publications can truly accelerate the progress
in this field leading to the development of novel targeted drugs. With this goal in mind, Journal of
Molecular Signaling, a journal fully devoted to open access publishing of rigorously peer-reviewed
quality manuscripts in the molecular signaling area of research, is being launched. The focus,
significance, and, the open access model of publishing of Journal of Molecular Signaling are
discussed.
Editorial
An open access journal of molecular signaling: a critical 
need at a critical time
"The free, unhampered exchange of ideas and scientific conclu-
sions is necessary for the sound development of science, as it is
in all spheres of life." (Albert Einstein, 1952).
At a time where new theories and discoveries are being
made almost on a daily basis, it is essential for the scien-
tific community to have free and ready access to these new
findings in order to accelerate further progress. It is also
important to make sure that the dissemination of scien-
tific information transcends the geopolitical as well as
economical barriers so that it reaches all in the far corners
of the world. A forum for such a free and rapid flow of sci-
entific information is acutely needed for the molecular
signaling area of research. Molecular signaling is an expo-
nentially growing field that encompasses different molec-
ular aspects of cell signaling underlying normal and
pathological conditions. This area also focuses on defin-
ing the genetic and epigenetic changes that modulate the
signaling properties of cells and the resultant physiologi-
cal as well as pathological conditions. Defining molecular
events in cell signaling forms the basis for identifying
novel diagnostic, prognostic, and therapeutic targets for
many different diseases. Therefore, rapid publication of
results from these endeavors and, more importantly, free
access to such publications can truly accelerate the
progress in this field leading to the development of novel
targeted drugs. With this goal in mind, Journal of Molecular
Signaling under the umbrella of BioMed Central's open
access publishing platform, will be fully devoted to open
access publishing of rigorously peer-reviewed quality
manuscripts in the molecular signaling area of research.
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The open access model of publishing has several advan-
tages over the traditional subscription-based access (both
print as well as online) to research information [1,2]. The
immediate benefits to the authors are 1) the free and uni-
versal visibility of the publication 2) author retention of
copyright privileges for the work along with the license to
allow anyone to reproduce and disseminate the published
article provided due attribution is given to the author and
3) the archival of the published articles in the repositories
such as PubMed Central of the US National Library of
Medicine [3], University of Potsdam in Germany [4],
INIST in France [5], and e-depot of National Library of the
Netherlands [6]. Likewise, the key benefits of open access
to the scientific community and the general public can
also be enumerated [7-12]. First, open access allows
authors to reach a large number of targeted readers imme-
diately and irrespective of their locations [7,11,12]. In
fact, such an enhanced readership in the open access
model has been correlated with the progressively increas-
ing impact factor of these journals [8-10]. Second, open
access readily eliminates the economical disparity in
accessing vital scientific information [11,12]. Third, the
central archiving that has become inherent to the open
access journals, allows enhanced literature search and
meta-analyses of data [3-6,13]. Fourth, considering the
fact that most research endeavors are funded by the tax-
payers, open access journals strive to make sure that the
outcome of these research efforts are accessible to the pub-
lic free of cost [14-17].
The major focus of Journal of Molecular Signaling will be on
the signaling pathways involved in proliferation, differen-
tiation, apoptosis, and oncogenesis in the mammalian
systems. Specifically, the research area of our journal is on
the normal or aberrant molecular mechanisms involving
receptors, G-proteins, kinases, phosphatases, and tran-
scription factors in regulating cell proliferation, differenti-
ation, apoptosis, and oncogenesis in mammalian cells.
With the launch of this journal, we hope to provide up-to-
date information to researchers in this rapidly growing
field of interest that is molecular signaling. With this jour-
nal, our goals are to a) simplify the search process by
focusing on a specific set of signaling pathways and b)
provide a high quality scientific journal in an open access
forum at the touch of a keyboard. We have an excellent
editorial board consisting of highly distinguished scien-
tists [18], who will assure fair and unbiased peer-review.
Articles will be published immediately upon acceptance
and the published articles will be indexed in PubMed [19]
and archived in the repositories previously noted, includ-
ing PubMed Central [3-6].
We, the editorial team of the Journal of Molecular Signaling,
will make every effort to publish exceptional and interest-
ing manuscripts that will have great impact in molecular
and cell signaling research. We also hope to publish topi-
cal reviews and commentaries from the experts in differ-
ent areas of signaling research. With your comments and
input, we will ensure that the journal meets your needs.
We are looking forward to the submission of your next
important manuscript to the Journal of Molecular Signaling
for the continued success of this journal.
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